IMIDAZONAPHTHYRIDINES
Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.
1 - 26 . (canceled)
27 . A container comprising a compartment containing at least one substance, wherein the at least one substance comprises a compound of formula (I)
in a pharmaceutically acceptable form.
28 . A container of claim 27 , wherein the pharmaceutically acceptable form is chosen from salts of the compound of formula (I) and solvates of the compound of formula (I).
29 . A container of claim 27 , wherein the pharmaceutically acceptable form is chosen from salts of the compound of formula (I).
30 . A container of claim 27 , wherein the pharmaceutically acceptable form is chosen from solvates of the compound of formula (I).
31 . A container of claim 27 , wherein the pharmaceutically acceptable form is the compound of formula (I).
32 . A container of claim 27 , wherein the at least one substance is the compound of formula (I).
33 . A container of claim 27 , wherein the at least one substance is a salt of the compound of formula (I).
34 . A container of claim 27 , wherein the at least one substance is a solvate of the compound of formula (I).
35 . A container comprising a compartment containing at least two substances, wherein the at least two substances comprise:
a compound of formula (I)
in a pharmaceutically acceptable form and
at least one pharmaceutically acceptable carrier.
36 . A container according to claim 35 , wherein the pharmaceutically acceptable form is chosen from salts of the compound of formula (I) and solvates of the compound of formula (I).
37 . A container according to claim 35 , wherein the pharmaceutically acceptable form is chosen from salts of the compound of formula (I).
38 . A container according to claim 35 , wherein the pharmaceutically acceptable form is chosen from solvates of the compound of formula (I).
39 . A container according to claim 35 , wherein the pharmaceutically acceptable form is the compound of formula (I).
40 . A container according to claim 35 , wherein the at least one substance is the compound of formula (I).
41 . A container of claim 35 , wherein the at least two substances are a salt of the compound of formula (I) and at least one pharmaceutically acceptable carrier.
42 . A container of claim 35 , wherein the at least two substances are a solvate of the compound of formula (I) and at least one pharmaceutically acceptable carrier.